Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Natsuko Furukawa"'
Autor:
Darrel W. Stafford, Xuejie Chen, G. Paul Savage, Jian Ke Tie, Da Yun Jin, Natsuko Furukawa, Craig M. Williams, Yizhou Liu, Yoshitomo Suhara
Publikováno v:
J Thromb Haemost
Background Vitamin K antagonists (VKAs), such as warfarin, have remained the cornerstone of oral anticoagulation therapy in the prevention and treatment of thromboembolism for more than half a century. They function by impairing the biosynthesis of v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88a290a0d30b1a29431d64ee3af1ffdb
https://doi.org/10.1111/jth.15209
https://doi.org/10.1111/jth.15209
Autor:
Natsuko Furukawa, Xuejie Chen, Satoshi Asano, Marina Matsumoto, Yuxin Wu, Kohei Murata, Atsuko Takeuchi, Chisato Tode, Taiki Homma, Ryohto Koharazawa, Kouki Usami, Jian-Ke Tie, Yoshihisa Hirota, Yoshitomo Suhara
Publikováno v:
Journal of Molecular Structure. 1276:134614
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1d05e50b71c0161d4249f900670d0e2
https://doi.org/10.1016/j.molstruc.2022.134614
https://doi.org/10.1016/j.molstruc.2022.134614
Autor:
Jian Ke Tie, Darrel W. Stafford, Yoshitomo Suhara, Natsuko Furukawa, Xuejie Chen, Craig M. Williams, Da-Yun Jin, Yizhou Liu
Publikováno v:
FEBS J
UbiA prenyltransferase domain-containing protein-1 (UBIAD1) is responsible for the biosynthesis of menaquinone-4 (MK-4), a cofactor for extrahepatic carboxylation of vitamin K-dependent (VKD) proteins. Genetic variations of UBIAD1 are mainly associat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7c00b7efba7a2c6d6f0f16386a89024
https://pubmed.ncbi.nlm.nih.gov/34813684
https://pubmed.ncbi.nlm.nih.gov/34813684
Autor:
Toshihiro Shizuku, Shuichi Sato, Natsuko Furukawa, Makoto Nagaoka, Hitomi Ishitobi, Hiroyuki Fukuhara, Mika Yuki, Nobuhiko Fukuba, Yoshiko Takahashi, Mutsuko Nishida, Yoshinori Komazawa, Miki Hayashi
Publikováno v:
Cureus
Background There have been very few studies on the association of polypharmacy with clinical course. In this paper, we seek to evaluate the relationship between polypharmacy and hospitalization period. Methods We retrospectively analyzed 322 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b21951e9d9040fde166a1a24046d96b5
https://doi.org/10.7759/cureus.7267
https://doi.org/10.7759/cureus.7267